Funko nearly went under. This former Netflix executive has a plan to revive the popular doll maker

Funko Inc., a publicly traded doll maker, reported a $67.4M loss in 2024 with $908.2M in sales, down 13%. The company faces debt and cash flow issues but is implementing a turnaround plan under new CEO Josh Simon, including diversifying supply chains and faster product releases. Second-quarter sales rose 7% to $207.7M, with net income of $15.4M, though including tariff refunds.

Original reporting
Published Sep 26, 2026, 10:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 26, 2026, 11:44 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Funko nearly went under. This former Netflix executive has a plan to revive the popular doll maker — source image
Decision brief

The 30-second read

Med
01

Why it matters

The Q2 earnings beat and profit reversal provide fresh material that could shift investor sentiment and price action.

02

Market read

First‑time reporting of Funko's Q2 profit and sales growth, a material earnings update for a small‑cap consumer discretionary stock.

03

What to watch

Potential volatility from future tariff adjustments and reliance on limited hit releases.

Relevance 7/10Novelty 7/10Timing: after-hours Friday

Background

Funko Inc., a NASDAQ‑listed maker of licensed Pop! figurines, has struggled with debt and declining sales, prompting a new CEO from Netflix.

Market effects

Positive signal for the broader collectibles and licensed‑merchandise sector.

May boost sentiment for other U.S. consumer discretionary stocks.

Limited to niche market; no broad macro effect.

Counterpoint

The turnaround may be short‑lived if supply‑chain shifts and licensing costs remain high.

Key entities

  • Josh Simon

    New CEO hired from Netflix, leading the turnaround.

  • Seaport Research Partners

    Provided buy rating and commentary on the earnings.

Related articles

$FNKOHigh

Why Funko (FNKO) Stock Is Trading Up Today

Funko (FNKO) shares rose 4.9% after Seaport Research initiated coverage with a Buy rating and $8 price target, citing growth in the collector market. The stock closed at $6.88, up 5.8% from the previous close. Funko reported a profitability turnaround and raised full-year adjusted EBITDA guidance to $100–$110 million.

$FNKOMed

Funko (FNKO) Q2 2026 Earnings Call Transcript

Funko (FNKO) reported Q2 2026 net sales of $207.7M, up 7% y/y, driven by core collectibles revenue of $171.6M (+9%). Gross margin was 56.6% including a $25.4M tariff refund credit; adjusted EBITDA was $40.9M. Full-year net sales guidance is flat to up 3%, and adjusted EBITDA guidance raised to $100M-$110M.

$FNKOMedAI 8/10

Why Are Funko (FNKO) Shares Soaring Today

Funko (NASDAQ: FNKO) shares rose 8.8% intraday, closing up 11.4% at $5.88, after the company reported a profitability turnaround and raised full-year adjusted EBITDA guidance to $100–$110 million from $70–$80 million. Funko swung to adjusted EPS of $0.26 and grew revenue 7.4% to $207.7 million, citing margin improvement and a tariff-related benefit.

$FNKOHigh

Funko Reports Strong Second Quarter 2026 Financial Results

Funko, Inc. (FNKO) filed an SEC Form 8-K — Results of Operations and Financial Condition. Funko Reports Strong Second Quarter 2026 Financial Results; Reiterates Full-Year Net Sales Outlook and Raises Adjusted EBITDA Guidance --Q2 Net Sales Grew 7%; Core Collectibles Sales Increased 9%; Record Gross Margin; Adjusted EBITDA Well Above Expectation; Debt Reduced by $15M -

$ARLPHighAI 8/10

Alliance Resource Partners (ARLP) Q3 2026 Earnings Call Transcript

Alliance Resource Partners (ARLP) reported Q3 2026 earnings with total revenues up 5.5% YoY to $603M, net income up 46.8% to $140M, and adjusted EBITDA up 26.3% to $234M. Coal sales volumes increased 7.4% YoY, with segment EBITDA up 18.6%. Oil and gas royalties set records, with revenues up 61.3% YoY. The company updated 2026 guidance, tightening ranges for coal and oil/gas segments. Debt stood at $680M, with liquidity at $431M and 673 Bitcoins valued at $56.3M.

$ABOSMed

Acumen Pharmaceuticals (ABOS) Q3 2026 Earnings Call Transcript

Acumen Pharmaceuticals (ABOS) reported Q3 2026 earnings, highlighting progress in its ALTITUDE-AD Phase II trial for Alzheimer's drug sabirnetug. The company expects top-line data in November, with potential registration package and Phase III trial planned. ABOS has $79M in cash, R&D expenses at $21.1M, and a net loss of $25.4M for the quarter. The company also discussed its enhanced brain delivery (EBD) program for Alzheimer's treatment, with IND filing expected in mid-2027.